Literature DB >> 7923893

Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle.

A G Stewart1, G Grigoriadis, T Harris.   

Abstract

1. Hyperplasia of airway smooth muscle contributes to the increase in bronchomotor responsiveness that characterizes asthma. We have investigated the mitogenic potential of endothelin-1 (ET-1) and epidermal growth factor (EGF) in guinea-pig cultured airway smooth muscle and the relationship of these actions to tyrosine phosphorylation and increases in intracellular calcium (Ca2+i). 2. ET-1 stimulated DNA and protein synthesis and also increased cell number, but these mitogenic actions were small compared with those of EGF. 3. ET-1 and EGF increased the level of tyrosine phophorylation of a range of proteins with apparent molecular weights between 80 and 100 kDa and also increased phosphorylation of a single protein of 33 kDa. 4. Ca2+i levels were increased by both ET-1 and EGF. However, concentrations of EGF three orders of magnitude higher than those having mitogenic actions or increasing protein tyrosine phosphorylation were required. ET-1 was a more potent stimulant of increases in intracellular calcium than of mitogenesis. 5. We conclude that elevation of Ca2+i is unlikely to be an important signal for the mitogenic action of EGF. It is suggested that stimulants at the EGF receptor (EGF and transforming growth factor alpha) may play a role in the airway smooth muscle hyperplasia in asthma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7923893     DOI: 10.1111/j.1440-1681.1994.tb02513.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  11 in total

Review 1.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration.

Authors:  J Kelley Bentley; Marc B Hershenson
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

2.  The effect of glucocorticoids on proliferation of human cultured airway smooth muscle.

Authors:  A G Stewart; D Fernandes; P R Tomlinson
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  The importance of ERK activity in the regulation of cyclin D1 levels and DNA synthesis in human cultured airway smooth muscle.

Authors:  C Ravenhall; E Guida; T Harris; V Koutsoubos; A Stewart
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle.

Authors:  Thai Tran; Alastair G Stewart
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 5.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

6.  Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon.

Authors:  R A Panettieri; R G Goldie; P J Rigby; A J Eszterhas; D W Hay
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

7.  Airway epithelial compression promotes airway smooth muscle proliferation and contraction.

Authors:  Bo Lan; Jennifer A Mitchel; Michael J O'Sullivan; Chan Young Park; Jae Hun Kim; William C Cole; James P Butler; Jin-Ah Park
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-02       Impact factor: 5.464

8.  Reconstruction is not renovation - the role of remodeling in asthma.

Authors:  Markus Weckmann; Thomas Trian; Brian Gg Oliver
Journal:  J Asthma Allergy       Date:  2009-03-16

9.  Smoking particles enhance endothelin A and endothelin B receptor-mediated contractions by enhancing translation in rat bronchi.

Authors:  Bengt W Granström; Cang-Bao Xu; Elisabeth Nilsson; Petter Vikman; Lars Edvinsson
Journal:  BMC Pulm Med       Date:  2006-03-15       Impact factor: 3.317

10.  The Oligo Fucoidan Inhibits Platelet-Derived Growth Factor-Stimulated Proliferation of Airway Smooth Muscle Cells.

Authors:  Chao-Huei Yang; Chiung-Fang Tsao; Wang-Sheng Ko; Ya-Ling Chiou
Journal:  Mar Drugs       Date:  2016-01-09       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.